Artículos de revistas sobre el tema "Du er ping kuang"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 31 mejores artículos de revistas para su investigación sobre el tema "Du er ping kuang".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Chi, Ya-Hui, Chun-Ping Chang, Teng-Kuang Yeh, Chiung-Tong Chen, Wan-Ping Wang, Yen-Ting Chen, Chia-Hua Tsai et al. "Abstract 5806: Discovery of a long half-life AURKA inhibitor to treat MYC-amplified solid tumors as a monotherapy and in combination with everolimus". Cancer Research 84, n.º 6_Supplement (22 de marzo de 2024): 5806. http://dx.doi.org/10.1158/1538-7445.am2024-5806.
Texto completoChi, Ya-Hui, Chun-Ping Chang, Teng-Kuang Yeh, Wan-Ping Wang, Yen-Ting Chen, Chia-Hua Tsai, Yan-Fu Chen et al. "Abstract 523: Targeting myc-amplified cancers with a novel prodrug inhibiting aurora A kinase". Cancer Research 83, n.º 7_Supplement (4 de abril de 2023): 523. http://dx.doi.org/10.1158/1538-7445.am2023-523.
Texto completoBall, Alexander, Yung Lin Hsieh, Chun Kai Huang, Sega Huang, Ping Kuan Hsieh, Shang Ru Wu, Yue Yun Chang, Jiming Liu, Po Shin Peng y Chia Yi Lin. "Abstract 1325: Novel recombinant rabbit monoclonal antibodies for cancer biology research". Cancer Research 83, n.º 7_Supplement (4 de abril de 2023): 1325. http://dx.doi.org/10.1158/1538-7445.am2023-1325.
Texto completoLi, Ning, Peng Jiang, Yuzhen Huang, Yuan TU, Wei Kong, Shan Jiang, Jingni Zhang et al. "Estrogen Receptor- And Progesterone Receptor-Positive Thresholds in Predicting the Recurrence of Early Low-Risk Endometrial Cancer". Clinical Medicine Insights: Oncology 16 (enero de 2022): 117955492211032. http://dx.doi.org/10.1177/11795549221103200.
Texto completoBondebjerg, Ib. "Kritisk teori, æstetik og receptionsforskning". MedieKultur: Journal of media and communication research 4, n.º 7 (26 de enero de 1988): 26. http://dx.doi.org/10.7146/mediekultur.v4i7.765.
Texto completoHou, Sharon S. J. y Huang Wei-liang. "Huo-yu te feng-hung: Yu Kuang-chung tso-p'in p'ing-lun chi (Huo-yu de feng-huang)---(Yu Guang-zhong zuo pin ping-lun ji)". Chinese Literature: Essays, Articles, Reviews (CLEAR) 7, n.º 1/2 (julio de 1985): 201. http://dx.doi.org/10.2307/495212.
Texto completoAgger, Gunhild. "Reklamen som pastiche. Om Dansk Sygeplejeråds annoncekampagne efteråret 1986". MedieKultur: Journal of media and communication research 5, n.º 10 (27 de marzo de 1989): 19. http://dx.doi.org/10.7146/mediekultur.v5i10.808.
Texto completoQuroturohman, Denis. "PENETRATION TESTING DALAM FORENSIK DIGITAL PADA JARINGAN FAKULTAS TEKNIK UNIVERSITAS IBN KHALDUN BOGOR DENGAN PING OF DEATH". Jurnal Inovatif : Inovasi Teknologi Informasi dan Informatika 4, n.º 2 (3 de noviembre de 2021): 81. http://dx.doi.org/10.32832/inova-tif.v4i2.5812.
Texto completoWang, Ping, Mariam Hassan y Anjan Chatterjee. "1493. The Incremental Burden of Nontuberculous Mycobacterial Lung Disease (NTMLD) among Patients with chronic obstructive pulmonary disease (COPD): Hospitalizations and ER Visits among US Medicare Beneficiaries". Open Forum Infectious Diseases 7, Supplement_1 (1 de octubre de 2020): S748—S749. http://dx.doi.org/10.1093/ofid/ofaa439.1674.
Texto completoChen, Mei-Kuang, Grace DeAlessandro, Tuyen Bui y Khandan Keyomarsi. "Abstract PO2-04-14: Dual Inhibition of WEE1 and PKMYT1 Synergistically Overcomes CDK4/6 Inhibitor Resistance in Breast Cancer". Cancer Research 84, n.º 9_Supplement (2 de mayo de 2024): PO2–04–14—PO2–04–14. http://dx.doi.org/10.1158/1538-7445.sabcs23-po2-04-14.
Texto completoLee, Pony Yu-Ling, Marvin A. Aberin, Chien-Chang Shen, Kun-Yuan Lin, Chao Di Chang, Chih-Chieh Yang, Shan-Yun Cheng, Ya Wen Hung, Xin-Guo Hsu y Shu-Ping Wang. "Abstract 5953: Reshaping the tumor microenvironment: new application of tamoxifen in triple negative breast cancer immunomodulation". Cancer Research 83, n.º 7_Supplement (4 de abril de 2023): 5953. http://dx.doi.org/10.1158/1538-7445.am2023-5953.
Texto completoLi, Hui-Ping, Qingyuan Zhang, Ruyan Zhang, Yaxin Liu y Xianjun Hu. "Abstract PO4-04-01: Antitumor activity and safety of sacibertinib (Hemay022) in combination with endocrine therapy in patients with ER and HER2 both positive metastatic breast cancer: A phase Ib study". Cancer Research 84, n.º 9_Supplement (2 de mayo de 2024): PO4–04–01—PO4–04–01. http://dx.doi.org/10.1158/1538-7445.sabcs23-po4-04-01.
Texto completoSun, Yu y Longhai Zhang. "Shakespeare across the Taiwan Strait: A Developmental Perspective". Multicultural Shakespeare: Translation, Appropriation and Performance 20, n.º 35 (30 de diciembre de 2019): 115–31. http://dx.doi.org/10.18778/2083-8530.20.09.
Texto completoLi, Hui-Ping, Qingyuan Zhang, Ruyan Zhang, Yaxin Liu, Chang Liu y Xianjun Hu. "Abstract PO2-27-11: Antitumor efficacy and safety of sacibertinib (Hemay022) in combination with endocrine therapy in patients with ER+ and HER2+ metastatic breast cancer: A phase Ib study". Cancer Research 84, n.º 9_Supplement (2 de mayo de 2024): PO2–27–11—PO2–27–11. http://dx.doi.org/10.1158/1538-7445.sabcs23-po2-27-11.
Texto completoYu, Kun, Tenghui Chen, Manav Korpal, Ping Zhu, Zhaojie Zhang, Lihua Yu y Yonghong Xiao. "Abstract 4123: Real-world data to identify the genomic association with response to CDK4/6i + Endocrine therapy in ER+ breast cancer patients". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): 4123. http://dx.doi.org/10.1158/1538-7445.am2022-4123.
Texto completoLi, Hui-Ping, Guohong Song, Hanfang Jiang, Xu Liang, Xiaojia Wang, Hua Yang, Lili Zhang y Youzhi Tong. "Abstract PS15-07: Proxalutamide plus Endocrine Therapies in Women with HR+/HER2-/AR+ Metastatic Breast Cancer: A Phase Ic Study". Cancer Research 84, n.º 9_Supplement (2 de mayo de 2024): PS15–07—PS15–07. http://dx.doi.org/10.1158/1538-7445.sabcs23-ps15-07.
Texto completoLu, Haizhen, Dong Kuang, Lili Jiang, Jingping Yun, Qingxin Xia, Jian Wang, Pei Duan et al. "Abstract 5463: The PD-L1 protein expression in Chinese patients with recurrent or metastatic head and neck squamous cell carcinoma: A multi-center retrospective study". Cancer Research 83, n.º 7_Supplement (4 de abril de 2023): 5463. http://dx.doi.org/10.1158/1538-7445.am2023-5463.
Texto completoZhao, Tianying, Shuai Xu, Jie Ping, Guochong Jia, Yongchao Dou, Bing Zhang, Xingyi Guo et al. "Abstract 1716: A proteome-wide association study identifies putative causal proteins for breast cancer". Cancer Research 84, n.º 6_Supplement (22 de marzo de 2024): 1716. http://dx.doi.org/10.1158/1538-7445.am2024-1716.
Texto completoWen, Kuang-Yi, Suzanne Miller, Aruna Padmanabhan, Rita Smith, Emmanuel Lapitan y Lori Goldstein. "Abstract B119: Effect of a smart pill bottle and text messaging-based intervention on medication adherence and side effect management in African American women with breast cancer new to endocrine therapy". Cancer Epidemiology, Biomarkers & Prevention 32, n.º 1_Supplement (1 de enero de 2023): B119. http://dx.doi.org/10.1158/1538-7755.disp22-b119.
Texto completoKubler, Kirsten, Agostina Nardone, Shankara Anand, Daniel Gorvich, Marjolein Droog, Francisco Hermida-Prado, Tara Akshi et al. "Abstract GS2-09: Tamoxifen instigates uterine cancer development by activating PI3K signaling and supersedes PIK3CA driver mutations". Cancer Research 82, n.º 4_Supplement (15 de febrero de 2022): GS2–09—GS2–09. http://dx.doi.org/10.1158/1538-7445.sabcs21-gs2-09.
Texto completoJabado, Omar, Suzana Couto, Jordan Blum, Patrick Franken, Patricia Coutinho de Souza, Maria Jure-Kunkel, Nora Pencheva, Brandon Higgs, Kate Sasser y Mark Fereshteh. "238 Molecular dissection of tumor-immune microenvironment factors associated with response to checkpoint inhibitor therapy in non-small cell lung cancer patients using nanostring digital spatial profiling". Journal for ImmunoTherapy of Cancer 8, Suppl 3 (noviembre de 2020): A255—A256. http://dx.doi.org/10.1136/jitc-2020-sitc2020.0238.
Texto completoAberin, Marvin A., Yu-Ling (Pony) Lee, Xin-Guo Hsu, Chen-Yang Shen, Yao-Ming Chang, Kun-Yuan Lin, Chandan Guha y Shu-Ping Wang. "Abstract 3646: New functional role of tamoxifen in breast cancer immunomodulation: role of RACK7 in activation of type I interferon signaling and CEACAM1/TIM-3-dependent immunosuppression". Cancer Research 83, n.º 7_Supplement (4 de abril de 2023): 3646. http://dx.doi.org/10.1158/1538-7445.am2023-3646.
Texto completoHuang, Lisi, Xin Du, Jianyu Weng, Peilong Lai, Zesheng Lu, Ping Wu, Suijing Wu, Chengwei Luo, Xin Huang y Suxia Geng. "Comparison of the 5 Year Medical Outcome and Quality of Life of Patients with Chronic Myeloid Leukemia Treated with Imatinib or Allogeneic Transplant". Blood 126, n.º 23 (3 de diciembre de 2015): 2118. http://dx.doi.org/10.1182/blood.v126.23.2118.2118.
Texto completoLiang, Yuehua, Hui Ping Li y Zehui Yun. "Abstract C035: Chemotherapy plus HER2-targeted therapy versus endocrine therapy plus HER2-targeted therapy as first-line treatment in patients with HR+/HER2+advanced breast cancer: A real-world trial". Molecular Cancer Therapeutics 22, n.º 12_Supplement (1 de diciembre de 2023): C035. http://dx.doi.org/10.1158/1535-7163.targ-23-c035.
Texto completoPuca, Loredana, Michele S. Dowless, Carmen M. Perez-Ferreiro, Maria Jesus Ortiz-Ruiz, Gregory P. Donoho, Andrew Capen, Lysiane Huber et al. "Abstract P4-08-02: LOXO-783: A potent, highly mutant selective and brain-penetrant allosteric PI3Kα H1047R inhibitor in combination with standard of care (SOC) treatments in preclinical PI3Kα H1047R-mutant breast cancer models". Cancer Research 83, n.º 5_Supplement (1 de marzo de 2023): P4–08–02—P4–08–02. http://dx.doi.org/10.1158/1538-7445.sabcs22-p4-08-02.
Texto completoLuo, Ting, Xiaorong Zhong, Ping He, Dan Zheng, Yan Cheng y Kunrui Zhu. "Abstract PO4-18-03: Combined Treatment with Pyrotinib and Chrysin Synergistically Improve the Autophagy Level in HER2-Positive Breast Cancer by Regulating the miR-16-5p/ZBTB16/G6PD Axis". Cancer Research 84, n.º 9_Supplement (2 de mayo de 2024): PO4–18–03—PO4–18–03. http://dx.doi.org/10.1158/1538-7445.sabcs23-po4-18-03.
Texto completoGrzegorczyk, Adrian y Marcin Mamajek. "A 70 W thulium-doped all-fiber laser operating at 1940 nm". Photonics Letters of Poland 11, n.º 3 (30 de septiembre de 2019): 81. http://dx.doi.org/10.4302/plp.v11i3.928.
Texto completoNielsen, Klaus Bo. "Xunzis ritualanalyse". Religionsvidenskabeligt Tidsskrift, n.º 51 (29 de febrero de 2008). http://dx.doi.org/10.7146/rt.v0i51.1715.
Texto completoPileberg, Silje. "Stabile tal for sjølvmord i Noreg". Suicidologi 25, n.º 3 (25 de enero de 2021). http://dx.doi.org/10.5617/suicidologi.8543.
Texto completoYang, Fang, Yonghui Yu y Hong Liu. "Mechanism of Action of Yikun Yitong Ping-Containing Serum on Mast Cells and its Possible Involvement in Endometriosis-Related Dysmenorrhea". Natural Product Communications 19, n.º 2 (febrero de 2024). http://dx.doi.org/10.1177/1934578x241229929.
Texto completoDung, Nguyen Thi, Hoang Van Thanh y Nguyen Dinh Lam. "Influences of Growth Durations on Characteristics of NaYF4:(Yb,Tm) Upconversion Materials". VNU Journal of Science: Natural Sciences and Technology 35, n.º 4 (23 de diciembre de 2019). http://dx.doi.org/10.25073/2588-1140/vnunst.4965.
Texto completo